Ironwood and CSO sued by Synergy over guanylate cyclase receptor agonists

Ironwood Pharmaceuticals, a Cambridge, Massachusetts biotechnology firm, is facing a lawsuit seeking $500 million in damages by Synergy Pharmaceuticals, a New York-based firm. Both firms are developing drugs in the gastro-intestinal area.